BioSpace News Archive

Illustration with one open hand under a question mark and another under a light bulb

Career Pathing

From Eli Lilly to Entrepreneur: A Journey to Independent Consulting

After more than 20 years at Eli Lilly, Leslie Sam moved into independent consulting. To prepare for the transition, she focused on becoming technically deep and earning industry recognition.

July 31, 2024

·

4 min read

·

Angela Gabriel

Sangamo's headquarters in Silicon Valley

Drug Development

Despite Late-Stage Hemophilia Win, Sangamo Remains in Do-or-Die Situation

Sangamo and Pfizer’s hemophilia A gene therapy candidate scored a Phase III victory last week. However, with the genomic medicine company soon to run out of cash, Sangamo’s short-term prospects look bleak but not unsalvageable, analysts say.

July 31, 2024

·

3 min read

·

Tyler Patchen

Pictured: Photo illustration of hundred dollar bill and graph

Deals

Biopharma Investment Activity Continued to Rise in Q2: J.P. Morgan

A report from J.P. Morgan shows an increase in biopharma activity so far this year and where some improvement can be made.

July 31, 2024

·

3 min read

·

Tyler Patchen

Round black and white wall clock at almost 6 o'clock on yellow background. Illustration of the concept of wake up time and off duty time

Career Advice

5 Quick Ways to Strengthen Your LinkedIn Profile in 60 Minutes

Companies will look at job candidates’ LinkedIn profiles, so make sure yours is strong, from the summary of your expertise and qualifications to testimonials from colleagues.

July 31, 2024

·

2 min read

·

BioSpace

Alzheimer’s disease

New Leqembi Data Illuminate Longer-Term Effects, Tau Reduction

Eisai presented a plethora of data on the drug at the Alzheimer’s Association International Conference, including a study showing the consequences of pausing treatment.

July 31, 2024

·

5 min read

·

Kate Goodwin

Novartis' office building in Marburg, Germany

Patents

FDA Denies Novartis’ Petition to Block Entresto Generics

In addition to facing generic competition, Entresto is among the initial 10 drugs selected for the Inflation Reduction Act’s Medicare Drug Price Negotiation Program, with the maximum fair prices to be published by Sept. 1.

July 31, 2024

·

2 min read

·

Tristan Manalac

Policy

BIOSECURE Act Could Signal a Seismic Shift for Biopharma in US and China

The BIOSECURE Act’s prohibition on doing business with China-based companies may have implications for biotech and biopharma markets on both sides of the Pacific.

July 31, 2024

·

8 min read

·

Sanjukta Mondal

Podcasts

Q2 Earnings Bonanza, M&A Accelerates and Alzheimer’s Data

Second-quarter earnings season continues with Big Pharma beating Wall Street expectations, the author of an encrypted email sent to BioSpace has a proposal for Moderna and Merck, Roche and Viking seek quicker entry to the obesity market, and AAIC is in full swing.

July 31, 2024

·

1 min read

·

Greg Slabodkin

Entrance to the Vertex's headquarters building in Boston, Massachusetts

Pain

Vertex Nabs Priority Review for Non-Opioid Pain Drug, Awaits January 2025 Decision

The FDA will have six months to review Vertex Pharmaceuticals’ suzetrigine, potentially the first new class of drugs for acute pain in more than 20 years, according to the company.

July 31, 2024

·

2 min read

·

Tristan Manalac

Pipeline

Incyte Trims Early-Stage Pipeline Amid Strategic Shift in R&D

Incyte announced Tuesday it is realigning its research and development priorities to focus on dermatology and inflammatory assets obtained from the $750 million acquisition of Escient Pharmaceuticals.

July 31, 2024

·

2 min read

·

Tristan Manalac